SCHEMBL5465664

SCHEMBL5465664

Cc1cccc(CO)c1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.41
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
MAPK8 P45983 2/20 0.38
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CD38 P28907 1/20 0.38
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
EPHB4 P54760 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PTGS2 P35354 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
HPGD P15428 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2857937 0.86 GABRA1 (0.45) PARP1MAPK8EPHB4TDP1PTGS2
SCHEMBL623350 0.82 L3MBTL1 (0.49) PDCD1CD274TDP1L3MBTL1PTGS2
SCHEMBL311565 0.81 PARP1 (0.46) PARP1EPHB4TDP1L3MBTL1ALDH1A1
SCHEMBL7843739 0.79 BID (0.49) KDM4E
SCHEMBL2129165 0.78 PARP1 (0.46) PARP1AURKARPS6KB1CD38L3MBTL1
SCHEMBL11316699 0.77 ALDH1A1 (0.41) PDCD1CD274MAPK8CD38L3MBTL1
SCHEMBL5545065 0.77 ALDH1A1 (0.47) AURKARPS6KB1ALDH1A1MEN1BLM
SCHEMBL27960770 0.77 CES2 (0.48) PARP1MAPK8AURKARPS6KB1TDP1
SCHEMBL8100279 0.75 FNTA (0.49) TDP1L3MBTL1PTGS2ALDH1A1MEN1
SCHEMBL14145347 0.74 PDCD1 (0.47) PDCD1CD274ALDH1A1TAAR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 PARP1 4364/4885PDCD1 4691/4885CD274 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.